Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOCO GROUP PLC Director's Dealing 2019

Dec 10, 2019

4931_dirs_2019-12-10_b26512df-734c-42b8-bd7a-b4d537951b8a.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3754W

Nanoco Group PLC

10 December 2019

10 December 2019

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

Notice of transactions by persons discharging managerial responsibility

As set out in the Company's 2019 Annual Report, and in the RNS on 1 November 2019 detailing an initial grant of deferred share awards in respect of the Executive Directors' annual bonuses for FY19, the Board was seeking shareholder approval for a resolution at the AGM on 5 December 2019 to amend the remuneration policy to allow up to 100% of any annual bonus earned to be paid in deferred share awards. The previous policy was a maximum of 50% in deferred shares with the balance to be paid in cash. The Board consider this change to be in the best interests of the Company by creating additional scope to conserve cash resources.

The relevant resolution was approved by shareholders at the AGM on 5th December 2019 with 99.8% of votes cast in favour. Subject to and following this approval, Nanoco has now granted to the Executive Directors, nil-cost options over ordinary shares in the Company in respect of the second half their annual bonus awards for FY19 as set out below.

Name of Director Number of options granted
Michael Edelman (CEO) 731,151
Nigel Pickett (CTO) 437,681
Brian Tenner (COO / CFO) 521,634

For the avoidance of doubt, the approved policy amendment had no impact on the actual amount or maximum amount of bonus that was earned in FY19 or can be earned in future years.

Ordinarily, the options will vest following the announcement of Nanoco's results for its financial year ending 31 July 2021. There are no further performance conditions attached to these options.

This notification is made pursuant to Disclosure and Transparency Rule 3.1.4. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

For further information, please contact:

Nanoco Group PLC Tel: +44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
Brian Tenner, Chief Financial Officer
Caroline Watson, Investor Relations Manager Tel: + 44 (0) 7799 897357
[email protected]
MHP Communications Tel: +44 (0) 20 3128 8570
Reg Hoare / Giles Robinson / Pete Lambie

[email protected]

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials through an extensive and unique IP portfolio of over 750 patents and patents pending with world leading R&D capabilities and high capacity production facilities. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

MICHAEL EDELMAN

2.

Reason for the notification

a)

Position /status

CHIEF EXECUTIVE OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:

Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 731,151

d)

Aggregated information:

- Aggregated volume

- Price

N/A

e)

Date of the transaction

10 December 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

DR NIGEL PICKETT

2.

Reason for the notification

a)

Position /status

CHIEF TECHNICAL OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:

Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 437,681

d)

Aggregated information:

- Aggregated volume

- Price

N/A

e)

Date of the transaction

10 December 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

BRIAN TENNER

2.

Reason for the notification

a)

Position /status

CHIEF OPERATING OFFICER & CHIEF FINANCIAL OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:

Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 521,634

d)

Aggregated information:

- Aggregated volume

- Price

N/A

e)

Date of the transaction

10 December 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHCKKDDDBDDQBD